Faraz Ali

CIK: 0001667937

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)15 (68.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)3 (13.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TNYA

Tenaya Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

TNYA
Tenaya Therapeutics, Inc.
Sep 10, 2026
Award(A)
Direct
122K shares-
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
4K shares at avg. $0.71$3K
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
5K shares at avg. $0.71$4K
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
7.4K shares at avg. $0.71$5K
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
5.8K shares at avg. $0.71$4K
TNYA
Tenaya Therapeutics, Inc.
May 18, 2026
Sale(S)
Direct
3.4K shares at avg. $0.79$3K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
5K shares at avg. $0.64$3K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
4K shares at avg. $0.64$3K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
5.9K shares at avg. $0.64$4K
TNYA
Tenaya Therapeutics, Inc.
Feb 3, 2026
Award(A)
Direct
158.6K shares-
TNYA
Tenaya Therapeutics, Inc.
Nov 17, 2025
Sale(S)
Direct
3.1K shares at avg. $1.33$4K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
3.9K shares at avg. $1.25$5K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
5.7K shares at avg. $1.25$7K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
4.9K shares at avg. $1.25$6K
TNYA
Tenaya Therapeutics, Inc.
May 16, 2025
Sale(S)
Direct
3.2K shares at avg. $0.44$1K
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
3.9K shares at avg. $0.54$2K
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
5.8K shares at avg. $0.54$3K
TNYA
Tenaya Therapeutics, Inc.
Feb 6, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
161.2K shares-
TNYA
Tenaya Therapeutics, Inc.
Feb 6, 2025
Award(A)
Direct
34.4K shares-
TNYA
Tenaya Therapeutics, Inc.
Feb 6, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
401.4K shares-
TNYA
Tenaya Therapeutics, Inc.
Feb 6, 2025
Award(A)
Direct
107.5K shares-
TNYA
Tenaya Therapeutics, Inc.
Feb 6, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
353.3K shares-

		Type	Shares	Price		Ownership
Sep 10, 2026	TNYA Tenaya Therapeutics, Inc.	Award(A)	122,000	-	$0	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,969	$0.71	$2,817	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	5,020	$0.71	$3,563	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	7,406	$0.71	$5,256	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	5,837	$0.71	$4,143	Direct
May 18, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,390	$0.79	$2,690	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	5,032	$0.64	$3,236	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,979	$0.64	$2,559	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	5,851	$0.64	$3,762	Direct
Feb 3, 2026	TNYA Tenaya Therapeutics, Inc.	Award(A)	158,600	-	$0	Direct
Nov 17, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,126	$1.33	$4,158	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,893	$1.25	$4,878	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	5,720	$1.25	$7,167	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	4,920	$1.25	$6,165	Direct
May 16, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,189	$0.44	$1,412	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,947	$0.54	$2,125	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	5,794	$0.54	$3,119	Direct
Feb 6, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	161,214	-	-	Direct
Feb 6, 2025	TNYA Tenaya Therapeutics, Inc.	Award(A)	34,424	-	-	Direct
Feb 6, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	401,390	-	-	Direct
Feb 6, 2025	TNYA Tenaya Therapeutics, Inc.	Award(A)	107,500	-	-	Direct
Feb 6, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	353,271	-	-	Direct

1-22 of 22 transactions

About Ali Faraz

Ali Faraz (SEC CIK 0001667937) files insider reports with the SEC as Chief Executive Officer of Tenaya Therapeutics, Inc. (TNYA).

Signal8 holds 10 ownership filings by Ali Faraz, all Form 4s, filed between Feb 7, 2025 and Sep 11, 2026. Those filings report 22 transactions, from Feb 6, 2025 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ali Faraz's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Ali Faraz

Sep 10, 2026: Grant or award of TNYA shares (Form 4, code A).
Aug 17, 2026: Open-market sales of TNYA shares (4 lines, Form 4, code S).
May 18, 2026: Open-market sale of TNYA shares (Form 4, code S).
Feb 17, 2026: Open-market sales of TNYA shares (3 lines, Form 4, code S).
Feb 3, 2026: Grant or award of TNYA shares (Form 4, code A).

Other insiders filing for Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore, Chief Medical Officer
Hyllengren Eric J, Chief Financial Officer
Williams R Sanders, Director
Walsh Jeffrey T., Director
Stehman-Breen Catherine, Director
Srivastava Deepak, Director

How to read Form 4 transaction codes